These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4252395)

  • 41. [Coagulation-physiological manifestations and clinical side-effects of streptokinase therapy].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):468-71. PubMed ID: 63434
    [No Abstract]   [Full Text] [Related]  

  • 42. [CLINICAL ASPECT OF FIBRINOLYSIS].
    BARTA I
    Orv Hetil; 1963 Aug; 104():1590-3. PubMed ID: 14052314
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator.
    Booth NA; Anderson JA; Bennett B
    J Clin Pathol; 1984 Jul; 37(7):772-7. PubMed ID: 6235248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromogenic assay for equine plasminogen.
    Welles EG; Prasse KW; Duncan A
    Am J Vet Res; 1990 Jul; 51(7):1080-5. PubMed ID: 1697146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Plasminogen (PG), plasmin (PM)].
    Sakuragawa N
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():51-4. PubMed ID: 8753178
    [No Abstract]   [Full Text] [Related]  

  • 46. [Plasminogen (PG), plasmin (PM)].
    Ohta S; Sakuragawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():667-70. PubMed ID: 10543208
    [No Abstract]   [Full Text] [Related]  

  • 47. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Plasminogen (PG) and plasmin (PM)].
    Kondo S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():697-9. PubMed ID: 15658427
    [No Abstract]   [Full Text] [Related]  

  • 49. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction].
    Goto S; Kawai Y; Watanabe K; Hori S; Abe S; Handa S; Ikeda Y
    Kokyu To Junkan; 1992 Jan; 40(1):89-95. PubMed ID: 1532665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Staphylokinase--a specific plasminogen activator].
    Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
    Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.
    Robbins KC; Summaria L; Hsieh B; Shah RJ
    J Biol Chem; 1967 May; 242(10):2333-42. PubMed ID: 4226004
    [No Abstract]   [Full Text] [Related]  

  • 55. A rapid and sensitive proteolytic assay for human plasminogen and plasmin using radioiodinated alpha-casein.
    Highsmith RF; Rosenberg RD
    Thromb Res; 1977 Aug; 11(2):131-40. PubMed ID: 143734
    [No Abstract]   [Full Text] [Related]  

  • 56. Intermittent plasminogen-streptokinase treatment of deep vein thrombosis.
    Scully MF; Lane DA; Sagar S; Thomas DP; Kakkar VV
    Thromb Haemost; 1977 Feb; 37(1):162-9. PubMed ID: 138963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.
    Hellstern P; Doenecke P; Köhler M; Schwerdt H; Ozbek C; Miyashita C; Bette L; Wenzel E
    Drugs; 1987; 33 Suppl 3():183-5. PubMed ID: 3315589
    [No Abstract]   [Full Text] [Related]  

  • 58. [Intravenous coronary fibrinolysis with acylated streptokinase-plasmin].
    Martínez-Rios MA; Cárdenas-Loaeza M; Gil-Moreno M; González-Pliego JA; Soni J
    Gac Med Mex; 1986; 122(11-12):291-8. PubMed ID: 2953641
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
    Craveri A; Cerrini R; Repaci G; Saracino F
    G Clin Med; 1968 Dec; 49(12):1326-53. PubMed ID: 4242987
    [No Abstract]   [Full Text] [Related]  

  • 60. Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction.
    Munger MA; Forrence EA
    Clin Pharm; 1990 Jul; 9(7):530-40. PubMed ID: 2198125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.